Professor Dean Ho, head of the Department of Biomedical Engineering, has been elected a fellow of the American Association for the Advancement of Science (AAAS).
Fellows are elected by Association members on an annual basis in recognition of their outstanding contributions to advance science and technology. The lifetime honour is one of the most prestigious among academic researchers worldwide.
In its citation, the AAAS said Prof Ho's election as a fellow recognised his "distinguished contributions to the fields of artificial intelligence, digital medicine and nanomedicine, particularly for drug development and combination therapy design".
'Practice-changing healthcare innovation'
Commenting, Prof Ho said: "I'm deeply honoured by this recognition, which is a culmination of the tireless efforts from my team members and collaborators."
He added: "The core focus of our team has been to directly impact patients through practice-changing healthcare innovation by harnessing the multidisciplinary expertise needed to bridge ideation with downstream adoption. My team and I are grateful to the NUS community and broader Singapore ecosystem for providing an inspiration foundation for bringing accessible and optimised treatment to all."
Prof Ho is also Director of the N.1 Institute for Health (N.1) and the Institute for Digital Medicine (WisDM), both at NUS. He is the only Singapore-based individual among 564 scientists, engineers, and innovators from around the world elected to the 2021 class of AAAS Fellows.
The world's largest general scientific society, the AAAS was founded in 1874 and publishes the journal Science (www.sciencemag.org). It seeks to "advance science, engineering, and innovation throughout the world for the benefit of all people."
